|
Published by: Millennium Research
Published: Mar. 30, 2007
Table of Contents
- LIST OF EXHIBITS
- EXECUTIVE SUMMARY
- METHODOLOGY
- 1.0 US PERIPHERAL VASCULAR DEVICE OVERVIEW
- 1.1 Market Overview
- 1.1.1 Procedures, by Type
- 1.1.1.1 Endovascular Procedures
- 1.1.1.2 Surgical Procedures
- 1.1.2 Procedures, by Indication
- 1.1.2.1 Carotid
- 1.1.2.2 Renal
- 1.1.2.3 Iliac
- 1.1.2.4 Lower Extremity
- 1.1.2.5 Aorta
- 1.1.2.6 Arteriovenous Access
- 1.1.2.7 Inferior Vena Cava Filters
- 1.1.2.8 Emerging PVD Device Technology
- 2.0 US PERIPHERAL VASCULAR DEVICE MARKET
- 2.1 Market Overview
- 2.2 Market Analysis
- 2.2.1 Procedures
- 2.2.2 Market Forecast
- 2.2.3 Market Drivers and Limiters
- 2.3 Competitive Analysis
- 3.0 PERIPHERAL VASCULAR STENT MARKET
- 3.1 Market Overview
- 3.2 Market Analysis
- 3.2.1 Procedures
- 3.2.2 Procedures, by Stent Type
- 3.2.2.1 Bare-Metal Stent Procedures
- 3.2.2.2 Covered Stent Procedures
- 3.2.3 Procedures, by Indication
- 3.2.3.1 Carotid Artery Stenting
- 3.2.3.2 Renal Artery Stenting
- 3.2.3.3 Iliac Artery Stenting
- 3.2.3.4 Femoral Popliteal Artery Stenting
- 3.2.3.5 Infrapopliteal Artery Stenting
- 3.2.3.6 Other Stenting
- 3.2.4 Market Forecast
- 3.2.5 Market Forecast, by Stent Type
- 3.2.5.1 Bare-Metal Stent Market
- 3.2.5.2 Covered Stent Market
- 3.2.6 Market Forecast, by Indication
- 3.2.6.1 Carotid Stent Market
- 3.2.6.2 Renal Stent Market
- 3.2.6.3 Iliac Stent Market
- 3.2.6.4 Femoral-Popliteal Stent Market
- 3.2.6.5 Infrapopliteal Stent Market
- 3.2.6.6 Other Stent Market
- 3.2.7 Market Drivers and Limiters
- 3.3 Competitive Analysis
- 4.0 PTA BALLOON CATHETER MARKET
- 4.1 Market Overview
- 4.2 Market Analysis
- 4.2.1 Procedures
- 4.2.1.1 Carotid Artery PTA Procedures
- 4.2.1.2 Renal Artery PTA Procedures
- 4.2.1.3 Iliac Artery PTA Procedures
- 4.2.1.4 Femoral-Popliteal PTA Procedures
- 4.2.1.5 Infrapopliteal PTA Procedures
- 4.2.1.6 Arteriovenous PTA Procedures
- 4.2.1.7 Other PTA Procedures
- 4.2.2 Market Forecast
- 4.2.2.1 Standard PTA Market
- 4.2.2.2 Small PTA Market
- 4.2.2.3 High-Pressure PTA Market
- 4.2.2.4 Specialty PTA Market
- 4.2.2.5 Large PTA Market
- 4.2.3 Market Drivers and Limiters
- 4.3 Competitive Analysis
- 5.0 EMBOLIC PROTECTION DEVICE MARKET
- 5.1 Market Overview
- 5.2 Market Analysis
- 5.2.1 Procedures
- 5.2.1.1 Carotid EPD Procedures
- 5.2.1.2 Renal EPD Procedures
- 5.2.1.3 Other EPD Procedures
- 5.2.2 Market Forecast
- 5.2.2.1 Carotid EPD Market
- 5.2.2.2 Renal EPD Market
- 5.2.2.3 Other EPD Market
- 5.2.3 Market Drivers and Limiters
- 5.3 Competitive Analysis
- 5.3.1 Leading Competitors
- 5.3.2 Emerging Competitors
- 6.0 INFERIOR VENA CAVA FILTER MARKET
- 6.1 Market Overview
- 6.2 Market Analysis
- 6.2.1 Procedures
- 6.2.1.1 Filter Retrieval
- 6.2.2 Market Forecast
- 6.2.3 Market Drivers and Limiters
- 6.3 Competitive Analysis
- 6.3.1 Leading Competitors
- 6.3.2 Emerging Competitors
- 7.0 AORTIC STENT GRAFT MARKET
- 7.1 Market Overview
- 7.2 Market Analysis
- 7.2.1 Procedures
- 7.2.1.1 Abdominal Aortic Aneurysm Procedures
- 7.2.1.2 Thoracic Aorta Procedures
- 7.2.2 Market Forecast
- 7.2.2.1 Abdominal Aortic Aneurysm Stent Graft Market
- 7.2.2.2 Thoracic Stent Graft Market
- 7.2.3 Market Drivers and Limiters
- 7.3 Competitive Analysis
- 7.3.1 Leading Competitors
- 7.3.2 Emerging Competitors
- 8.0 SYNTHETIC SURGICAL GRAFT MARKET
- 8.1 Market Overview
- 8.2 Market Analysis
- 8.2.1 Procedures
- 8.2.1.1 ePTFE Graft Procedures
- 8.2.1.1.1 Arteriovenous Access Procedures
- 8.2.1.1.2 Lower Extremity Bypass Procedures
- 8.2.1.1.3 Other Bypass Procedures
- 8.2.1.2 Dacron Procedures
- 8.2.1.2.1 AAA Surgical Procedures
- 8.2.1.2.2 Thoracic Aortic Surgical Procedures
- 8.2.1.2.3 Extra-Anatomical Bypass Procedures
- 8.2.1.2.4 Aorto-Iliac Bypass Procedures
- 8.2.2 Market Forecast
- 8.2.2.1 ePTFE Surgical Graft Market
- 8.2.2.1.1 Arteriovenous Access Synthetic Graft Market
- 8.2.2.1.2 Lower Extremity Bypass Graft Market
- 8.2.2.1.3 Other Peripheral Bypass Graft Market
- 8.2.2.2 Dacron Surgical Graft Market
- 8.2.2.2.1 AAA Surgical Graft Market
- 8.2.2.2.2 Thoracic aortic Surgical Graft Market
- 8.2.2.2.3 Extra-Anatomical Surgical Graft Market
- 8.2.2.2.4 Aorto-Iliac Bypass Graft Market
- 8.2.3 Market Drivers and Limiters
- 8.3 Competitive Analysis
- 9.0 ACCESSORY DEVICE MARKET
- 9.1 Market Overview
- 9.2 Market Analysis
- 9.2.1 Procedures
- 9.2.1.1 PV Guidewires
- 9.2.1.2 PV Diagnostic Catheters
- 9.2.1.3 PV Sheaths
- 9.2.1.4 PV Guiding Catheters
- 9.2.2 Market Forecast
- 9.2.2.1 PV Guidewire Market
- 9.2.2.2 PV Diagnostic Catheter Market
- 9.2.2.3 PV Sheath Market
- 9.2.2.4 PV Guiding Catheter Market
- 9.2.3 Market Drivers and Limiters
- 9.3 Competitive Analysis
- MRG ACRONYMS AND INITIALISMS
- MRG List of Exhibits
- EXECUTIVE SUMMARY
- Exhibit ES-1: PV Device Market, by Device, as a % of Total, US, 2006
- Exhibit ES-2: PV Device Market, by Device, as a % of Total, US, 2005-2011
- Exhibit ES-3: PV Stent Market, by Indication, US (US$), 2005-2011
- Exhibit ES-4: PTA Balloon Catheter Market, by Type, as a % of Total, US, 2005-2011
- Exhibit ES-5: EPD Market, by Indication, US (US$), 2005-2011
- Exhibit ES-6: IVCF Market, by Type, as a % of Total, US, 2005-2011
- Exhibit ES-7: Aortic Procedures, by Type, US, 2005-2011
- Exhibit ES-8: Synthetic Surgical Graft Market, by Indication, as a % of Total, US, 2006
- Exhibit ES-9: PV Diagnostic and Interventional Procedures, US, 2005-2011
- Exhibit ES-10: Leading Competitors in the PV Market, US, 2006
- CHAPTER 1: US PERIPHERAL VASCULAR DEVICE OVERVIEW
- Exhibit 1-1: PVD Treatment Morbidities and Length of Stay, by Indication
- Exhibit 1-2: PVD Endovascular and Surgical Patency Rates, by Indication
- Exhibit 1-3: EPD Device Descriptions, by Device Type
- Exhibit 1-4: EPD Device Descriptions, by Device Type (Continued)
- Exhibit 1-5: Rupture Risk of Untreated AAA
- Exhibit 1-6: Vena Cava Filter Indications
- CHAPTER 2: US PERIPHERAL VASCULAR DEVICE MARKET
- Exhibit 2-1: PV Device Market, US (US$), 2005-2011
- Exhibit 2-2: PV Device Market, by Device, as a % of Total, US, 2006 and 2011
- Exhibit 2-3: PV Procedures, by Type, US, 2005-2011 (Graphical Format)
- Exhibit 2-4: PV Procedures, by Type, US, 2005-2011 (Tabular Format)
- Exhibit 2-5: Total PV Procedures, by Device Type, US, 2005-2011
- Exhibit 2-6: ATK Procedures, by Device Type, US, 2005-2011
- Exhibit 2-7: BTK Procedures, by Device Type, US, 2005-2011
- Exhibit 2-8: PV Market, by Device, US, 2005-2011 (Graphical Format)
- Exhibit 2-9: PV Market, by Device, US (US$), 2005-2011 (Tabular Format)
- Exhibit 2-10: Drivers of the PV Device Market, US
- Exhibit 2-11: Limiters of the PV Device Market, US
- Exhibit 2-12: Leading Competitors in the US PV Device Market, by Device, 2006
- CHAPTER 3: PERIPHERAL VASCULAR STENT MARKET
- Exhibit 3-1: PV Stent Market, US (US$), 2005-2011
- Exhibit 3-2: PV Stent Procedures, by Type, US, 2005-2011 (Graphical Format)
- Exhibit 3-3: PV Stent Procedures, by Type, US, 2005-2011
- Exhibit 3-4: PV Stent Procedure Growth, by Type, US, 2005-2011
- Exhibit 3-5: BMS Procedures, US, 2005-2011
- Exhibit 3-6: CS Units, by Indication, US, 2005-2011 (Graphical Format)
- Exhibit 3-7: CS Units, by Indication, US, 2005-2011 (Tabular Format)
- Exhibit 3-8: PV Stent Units, by Indication and Type, as a % of Total, US, 2006
- Exhibit 3-9: PV Stent Units, by Type and Indication, US, 2006
- Exhibit 3-10: PV Stent Procedures and Units, by Indication, US, 2005-2011
- Exhibit 3-11: PV Stent Procedure and Unit Growth, by Indication, US, 2006- 2011
- Exhibit 3-12: PV Stent Procedures and Units, by Indication, as a % of Total, US, 2005-2011
- Exhibit 3-13: PV Stent Units, by Indication and Type, as a % of Total, US, 2006
- Exhibit 3-14: PV Stent Market, by Type, US (US$), 2005-2011
- Exhibit 3-15: BMS Market, US (US$), 2005-2011
- Exhibit 3-16: PV Stent Market, by Type, US (US$), 2005-2011
- Exhibit 3-17: PV Stent Market Growth, by Type, US, 2006-2011
- Exhibit 3-18: PV Stent Market, by Indication, US (US$), 2005-2011 (Graphical Format)
- Exhibit 3-19: PV Stent Market, by Indication, as a % of Total, US, 2006 and 2011
- Exhibit 3-20: PV Stent Market, by Indication, US (US$), 2005-2011 (Tabular Format)
- Exhibit 3-21: PV Stent Market Growth, by Indication, US, 2006-2011
- Exhibit 3-22: PV Stent Market, by Indication, as a % of Total, US, 2005-2011
- Exhibit 3-23: Drivers of the PV Stent Market, US
- Exhibit 3-24: Limiters of the PV Stent Market, US
- Exhibit 3-25: Leading Competitors in the PV Stent Market, by Type, US, 2006
- Exhibit 3-26: Leading Competitors in the PV Stent Market, by Indication, US, 2006
- CHAPTER 4: PTA BALLOON CATHETER MARKET
- Exhibit 4-1: PTA Balloon Catheter Market, US (US$), 2005-2011
- Exhibit 4-2: Primary Indications, by PTA Balloon Catheter Type
- Exhibit 4-3: PTA Balloon Catheter Procedures and Units, by Indication and Type, US, 2006
- Exhibit 4-4: PTA Balloon Catheter Procedures, by Indication and Type, as a % of Total, US, 2006 (Tabular Format)
- Exhibit 4-5: PTA Balloon Catheter Procedures, by Indication and Type, as a % of Total, US, 2006 (Graphical Format)
- Exhibit 4-6: PTA Balloon Catheter Procedures, by Type, US, 2005-2011
- Exhibit 4-7: PTA Procedures, by Indication, US, 2005-2011
- Exhibit 4-8: PTA Procedures, by Indication, US, 2005-2011
- Exhibit 4-9: PTA Procedure Growth and % of Total, by Indication, US, 2005- 2011
- Exhibit 4-10: POBA Procedures, by Indication, US, 2005-2011
- Exhibit 4-11: POBA Procedures, by Indication, US, 2005-2011
- Exhibit 4-12: POBA Procedures, by Indication, as a % of Total, US, 2005-2011
- Exhibit 4-13: PTA with Stenting Procedures, by Indication, US, 2005-2011
- Exhibit 4-14: PTA with Stenting Procedures, by Indication, US, 2005-2011
- Exhibit 4-15: PTA with Stenting Procedures, by Indication, as a % of Total, US, 2005-2011
- Exhibit 4-16: PTA with Stenting Procedures, by Usage Type, as a % of Stent Procedures, US, 2006
- Exhibit 4-17: PTA Balloon Catheter Market, US (US$), 2005-2011 (Tabular Format)
- Exhibit 4-18: PTA Balloon Catheter Market, by Type, US (US$), 2005-2011 (Graphical Format)
- Exhibit 4-19: PTA Balloon Catheter Market, by Type, US (US$), 2005-2011 (Tabular Format)
- Exhibit 4-20: PTA Balloon Catheter Market Growth, by Type, US, 2006-2011
- Exhibit 4-21: PTA Balloon Catheter Market, by Type, as a % of Total, US, 2005-2011 (Graphical Format)
- Exhibit 4-22: PTA Balloon Catheter Market, by Type, as a % of Total, US, 2005-2011 (Tabular Format)
- Exhibit 4-23: Drivers of the PTA Balloon Catheter Market, US
- Exhibit 4-24: Limiters of the PTA Balloon Catheter Market, US
- Exhibit 4-25: Leading Competitors in the PTA Balloon Catheter Market, by Device Type, US, 2006
- CHAPTER 5: EMBOLIC PROTECTION DEVICE MARKET
- Exhibit 5-1: EPD Market, US (US$), 2005-2011
- Exhibit 5-2: EPD Procedures, by Indication, as a % of Total, US, 2005-2011
- Exhibit 5-3: EPD Procedures, by Indication, US, 2005-2011
- Exhibit 5-4: CAS Clinical Trial Update, 2006
- Exhibit 5-5: CAS Clinical Trial Update, 2006 (Continued)
- Exhibit 5-6: Important CAS with EPD Trial Results
- Exhibit 5-7: Carotid Stent Procedures and EPD Penetration, US, 2005-2011
- Exhibit 5-8: Renal Stent Procedures and EPD Penetration, US, 2005-2011
- Exhibit 5-9: EPD Market, by Indication, US (US$), 2005-2011 (Graphical Format)
- Exhibit 5-10: EPD Market, by Indication, US (US$), 2005-2011 (Tabular Format)
- Exhibit 5-11: EPD Market Growth, by Indication, US, 2006-2011
- Exhibit 5-12: EPD Units and Market Value, by Indication, as a % of Total, US, 2005-2011
- Exhibit 5-13: Carotid EPD Market, US (US$), 2005-2011
- Exhibit 5-14: Carotid EPD Market Growth, US, 2006-2011
- Exhibit 5-15: Renal EPD Market, US (US$), 2005-2011
- Exhibit 5-16: Renal EPD Market Growth, US, 2006-2011
- Exhibit 5-17: Drivers of the EPD Market, US
- Exhibit 5-18: Limiters of the EPD Market, US
- Exhibit 5-19: Leading Competitors in the EPD Market, by Indication, US, 2006
- Exhibit 5-20: Overview of EPDs, US, 2006
- Exhibit 5-21: Overview of EPDs, US, 2006 (Continued)
- Exhibit 5-22: CAS EPD Specifics
- CHAPTER 6: INFERIOR VENA CAVA FILTER MARKET
- Exhibit 6-1: IVCF Market, US (US$), 2005-2011
- Exhibit 6-2: Complications Associated with IVCF Use
- Exhibit 6-3: Indicated Safe Time of Removal for Retrievable IVCFs, 2006
- Exhibit 6-4: IVCF Units and Retrievable Kits, by Type, US, 2005-2011 (Graphical Format)
- Exhibit 6-5: IVCF Units, by Type, as a % of Total, US, 2005-2011
- Exhibit 6-6: IVCF Units and Retrievable Kits, by Type, US, 2005-2011 (Tabular Format)
- Exhibit 6-7: IVCF Market, by Type, US (US$), 2005-2011 (Graphical Format)
- Exhibit 6-8: IVCF Revenues, by Type, as a % of Total, US, 2005-2011
- Exhibit 6-9: IVCF Market, by Type, US (US$), 2005-2011 (Tabular Format)
- Exhibit 6-10: IVCF Market Growth, by Type, US, 2006-2011
- Exhibit 6-11: IVCF Market, by Type, as a % of Total, US, 2005-2011
- Exhibit 6-12: Drivers of the IVCF Market, US
- Exhibit 6-13: Limiters of the IVCF Market, US
- Exhibit 6-14: Leading Competitors in the IVCF Market, by Type, US, 2006
- CHAPTER 7: AORTIC STENT GRAFT MARKET
- Exhibit 7-1: Aortic Stent Graft Market, US (US$), 2005-2011
- Exhibit 7-2: AAA Stent Graft Device Overview, US, 2006
- Exhibit 7-3: Thoracic Stent Graft Device Overview, US, 2006
- Exhibit 7-4: FDA Approved AAA Stent Graft Clinical Trial Overview
- Exhibit 7-5: Aortic Stent Graft Procedures, by Indication, US, 2005-2011 (Graphical Format)
- Exhibit 7-6: Aortic Stent Graft Procedures, by Indication, US, 2005-2011 (Tabular Format)
- Exhibit 7-7: AAA Stent Graft Penetration into Total AAA Procedures, US, 2005- 2011
- Exhibit 7-8: Location of Thoracic Aortic Surgical Procedures, as a % of Total, US, 2006
- Exhibit 7-9: Thoracic Aortic Procedures, by Type, US, 2005-2011
- Exhibit 7-10: Thoracic Aortic Procedures, by Indication, US, 2005-2011
- Exhibit 7-11: Aortic Stent Graft Market, by Indication, US (US$), 2005-2011 (Graphical Format)
- Exhibit 7-12: Aortic Stent Graft Market, by Indication, US (US$), 2005-2011 (Tabular Format)
- Exhibit 7-13: Aortic Stent Graft Market, by Indication, as a % of Total, US, 2005-2011 (Graphical Format)
- Exhibit 7-14: Aortic Stent Graft Market, by Indication, as a % of Total, US, 2005-2011 (Tabular Format)
- Exhibit 7-15: AAA Stent Graft Market, US (US$), 2005-2011
- Exhibit 7-16: Thoracic Aortic Stent Graft Market, US (US$), 2005-2011
- Exhibit 7-17: Drivers of the Aortic Stent Graft Market, US
- Exhibit 7-18: Drivers of the Aortic Stent Graft Market, US (Continued)
- Exhibit 7-19: Limiters of the Aortic Stent Graft Market, US
- Exhibit 7-20: Leading Competitors in the US Aortic Stent Graft Market, by Type, 2006
- Exhibit 7-21: W.L. Gore’s TAG Device Pivotal Study Results
- CHAPTER 8: SYNTHETIC SURGICAL GRAFT MARKET
- Exhibit 8-1: Synthetic Surgical Graft Market, US (US$), 2005-2011
- Exhibit 8-2: Synthetic Surgical Graft Materials by Primary Indications
- Exhibit 8-3: Synthetic Surgical Graft Procedures, US, 2005-2011
- Exhibit 8-4: Synthetic Surgical Graft Procedures, by Indication, as a % of Total, US, 2005-2011 (Graphical Format)
- Exhibit 8-5: Synthetic Surgical Graft Procedures, by Indication, US, 2005- 2011
- Exhibit 8-6: Synthetic Surgical Graft Procedures, by Indication, as a % of Total, US, 2005-2011 (Tabular Format)
- Exhibit 8-7: Synthetic Surgical Graft Procedures, by Material, US, 2005-2011
- Exhibit 8-8: Synthetic Surgical Graft Market, by Material, US (US$), 2005- 2011 (Graphical Format)
- Exhibit 8-9: Synthetic Surgical Graft Market, by Material, US (US$), 2005- 2011 (Tabular Format)
- Exhibit 8-10: Synthetic Surgical Graft Market Growth, by Material, US, 2006- 2011
- Exhibit 8-11: Synthetic Surgical Graft Market, by Indication, US (US$), 2005- 2011 (Graphical Format)
- Exhibit 8-12: Synthetic Surgical Graft Market, by Indication, US (US$), 2005- 2011 (Tabular Format)
- Exhibit 8-13: Synthetic Surgical Graft Market Growth, by Indication, US, 2006-2011
- Exhibit 8-14: Synthetic Surgical Graft Market, by Indication, as a % of Total, US, 2005-2011
- Exhibit 8-15: Drivers of the Synthetic Surgical Graft Market, US
- Exhibit 8-16: Limiters of the Synthetic Surgical Graft Market, US
- Exhibit 8-17: Leading Competitors in the Synthetic Surgical Graft Market, by Material, US, 2006
- CHAPTER 9: ACCESSORY DEVICE MARKET
- Exhibit 9-1: Accessory Device Market, US (US$), 2005-2011
- Exhibit 9-2: PV Procedures, by Type, US, 2005-2011 (Tabular Format)
- Exhibit 9-3: PV Procedures, by Type, US, 2005-2011 (Graphical Format)
- Exhibit 9-4: Best Selling PV Guidewires, by Type, US, 2006
- Exhibit 9-5: Best Selling PV Diagnostic Catheters, by Type
- Exhibit 9-6: Best Selling PV Sheaths, by Type
- Exhibit 9-7: Best-Selling PV Guiding Catheters, US, 2006
- Exhibit 9-8: PV Accessory Device Market, by Device, US (US$), 2005-2011 (Graphical Format)
- Exhibit 9-9: PV Accessory Device Market, by Device, US (US$), 2005-2011 (Tabular Format)
- Exhibit 9-10: PV Accessory Device Market, by Device, US, 2006 and 2011
- Exhibit 9-11: PV Guidewire Market, by Type, US (US$), 2005-2011
- Exhibit 9-12: PV Guidewire Market Growth, by Type, US, 2006-2011
- Exhibit 9-13: PV Diagnostic Catheter Market, by Type, US (US$), 2005-2011
- Exhibit 9-14: PV Diagnostic Catheter Market Growth, by Type, US, 2006-2011
- Exhibit 9-15: PV Sheath Market, by Type, US (US$), 2005-2011
- Exhibit 9-16: PV Sheath Market Growth, by Type, US, 2006-2011
- Exhibit 9-17: PV Guiding Catheter Market, US (US$), 2005-2011
- Exhibit 9-18: Drivers of the Accessory Device Market, US
- Exhibit 9-19: Limiters of the Accessory Device Market, US
- Exhibit 9-20: Leading Competitors in the Accessory Device Market, US, 2006
AbstractThe PV market was valued at roughly $1.9 billion in 2006 and will increase at a rapid CAGR of over 10% throughout the forecast period.
The peripheral vascular (PV) device market comprises PV stents, percutaneous transluminal angioplasty (PTA) balloon catheters, embolic protection devices (EPDs), inferior vena cava filters (IVCFs), aortic stent grafts, synthetic surgical grafts, and accessory devices.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|